Benefits of testosterone treatment for frailty in older men are temporaryNovember 5th, 2010 - 1:58 pm ICT by ANI
Washington, Nov 5 (ANI): A new UK study found that the beneficial effects of testosterone treatment on muscle mass, strength and quality of life were not maintained at 6 months post-treatment in frail elderly men.
“Since the use of testosterone in elderly men raises concerns regarding adverse effects on the prostate and cardiovascular system, it’s important to determine if short-term treatment can lead to prolonged benefits beyond the duration of testosterone exposure,” said lead author Frederick Wu of the University of Manchester.
“Our findings suggest it may not be possible to break or interrupt the cycle of decline in physical function in frailty by short-term anabolic pharmacological intervention using testosterone supplementation for six months,” he added.
As testosterone levels naturally decrease with aging, loss of muscle mass and function in frail elderly men may result in poor outcomes such as dependency, institutionalization, and death.
Although short-term testosterone therapy in frail elderly men has been associated with increased muscle mass and strength, it was not previously determined whether these improvements would be maintained once therapy was stopped.
In this study, 274 intermediate-frail and frail elderly men aged 65 to 90 years with low testosterone levels were assigned to receive either a testosterone gel or placebo for six months.
Evaluations took place at baseline, 6 months (end of treatment), and 12 months (6 months after treatment was stopped).
On the basis of the findings, the researchers concluded that the effects of 6 months of treatment with testosterone on muscle strength, lean mass, and quality of life in frail men are not maintained at 6 months post-treatment.
“At present, the optimal duration of anabolic hormonal intervention to produce sustained benefits in treating frailty in older men is unknown,” said Wu.
“To best interrupt the downward spiral into frailty, a greater emphasis should be placed on a multidisciplinary interventional approach, including resistance exercise, diet, and other lifestyle options in conjunction with pharmacological agents,” he added.
The study will appear in the February 2011 issue of the Journal of Clinical Endocrinology & Metabolism. (ANI)
- High level of testosterone may speed up prostate cancer - Jul 31, 2012
- Higher testosterone helps older men preserve muscle mass - Oct 29, 2011
- Sleep loss can cause testosterone levels to plummet - Jun 01, 2011
- How hormonal and molecular responses to exercise differ by age - Jan 26, 2011
- Weight loss helps boost low testosterone levels - Jun 26, 2012
- Testosterone might not be the fountainhead of youth - Oct 23, 2011
- Does lacking testosterone make men frail? - Jul 09, 2010
- Stem cells bulk up muscle, halt ageing - Nov 11, 2010
- Male menopause affects over 5m men - Aug 21, 2010
- Soccer cuts risk of falls and bone fractures - Mar 04, 2010
- Mouse-sized device that heals muscle pain - Sep 10, 2012
- Hormone therapy 'doubles survival chances in men with prostate cancer' - Mar 25, 2011
- Low testosterone 'may raise risk of early death' - Oct 20, 2010
- How testosterone fights blues - Apr 03, 2012
- Symptoms of 'male menopause' identified - Jun 17, 2010
Tags: adverse effects, beneficial effects, cardiovascular system, downward spiral, elderly men, frailty, institutionalization, lean mass, low testosterone levels, muscle mass, muscle strength, nov 5, older men, optimal duration, pharmacological intervention, poor outcomes, testosterone, testosterone gel, testosterone therapy, university of manchester